ROTATEQ

Google image searchProduct monograph

Active ingredients

human-bovine rotavirus reassortant type g1, 2210000 UNIT/DOSE

human-bovine rotavirus reassortant type g2, 2840000 UNIT/DOSE

human-bovine rotavirus reassortant type g3, 2220000 UNIT/DOSE

human-bovine rotavirus reassortant type g4, 2040000 UNIT/DOSE

human-bovine rotavirus reassortant type p1(8), 2290000 UNIT/DOSE

DIN: 02284413

Dosage form(s): SOLUTION

Route(s) of administration: ORAL

Description: ROTAVIRUS VACCINE, LIVE, ORAL, PENTAVALENT. PREFILLED 2ML UNIT DOSE TUBE

Schedule: Schedule D

Company: MERCK CANADA INC

Date: 16-OCT-2006

ATC:

• J07 — VACCINES (ATC, ATC/DDD, )
• J07B — VIRAL VACCINES (ATC, ATC/DDD)
• J07BH — Rota virus diarrhea vaccines (ATC, ATC/DDD)
• J07BH02 — ROTA VIRUS, PENTAVALENT, LIVE, REASSORTED (ATC/DDD)

External Links for Rotateq

Search on Google

• Rotateq side effects
• Rotateq dosage
• human-bovine rotavirus reassortant type g1 side effects
• human-bovine rotavirus reassortant type g1 dosage
• human-bovine rotavirus reassortant type g2 side effects
• human-bovine rotavirus reassortant type g2 dosage
• human-bovine rotavirus reassortant type g3 side effects
• human-bovine rotavirus reassortant type g3 dosage
• human-bovine rotavirus reassortant type g4 side effects
• human-bovine rotavirus reassortant type g4 dosage
• human-bovine rotavirus reassortant type p1(8) side effects
• human-bovine rotavirus reassortant type p1(8) dosage

Merck Canada Inc

Go to Merck website to see drug product details. Sometimes you can find rotateq photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.